Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
0.6175
-0.0170 (-2.68%)
At close: Oct 31, 2025, 4:00 PM EDT
0.6122
-0.0053 (-0.86%)
After-hours: Oct 31, 2025, 7:39 PM EDT
Lifeward Revenue
Lifeward had revenue of $5.72M in the quarter ending June 30, 2025, a decrease of -14.66%. This brings the company's revenue in the last twelve months to $24.43M, up 4.96% year-over-year. In the year 2024, Lifeward had annual revenue of $25.66M with 85.24% growth.
Revenue (ttm)
$24.43M
Revenue Growth
+4.96%
P/S Ratio
0.25
Revenue / Employee
$305,388
Employees
80
Market Cap
9.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.66M | 11.81M | 85.24% |
| Dec 31, 2023 | 13.85M | 8.34M | 151.39% |
| Dec 31, 2022 | 5.51M | -455.00K | -7.63% |
| Dec 31, 2021 | 5.97M | 1.57M | 35.81% |
| Dec 31, 2020 | 4.39M | -480.00K | -9.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
LFWD News
- 7 weeks ago - First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton - GlobeNewsWire
- 7 weeks ago - Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton - GlobeNewsWire
- 2 months ago - Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Lifeward Ltd. Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership - GlobeNewsWire
- 3 months ago - Lifeward to Report Second Quarter Financial Results on August 14, 2025 - GlobeNewsWire
- 3 months ago - Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region - GlobeNewsWire
- 4 months ago - MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion - PRNewsWire